source

Bright Minds Biosciences toPresent at Upcoming Conferences

October 30, 2025 18:30 ET  | Source: Bright Minds Biosciences NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Bright Minds…

4 months ago

FLAMGP:AI Computing Power is Transforming the Earning Model of BTC, XRP, and Other Digital Assets

Pittsburgh, Pennsylvania, Oct. 30, 2025 (GLOBE NEWSWIRE) --  The crypto market is undergoing a major overhaul in 2025. Although there…

4 months ago

ROSEWOOD HONG KONG NAMED NO.1 IN THE WORLD’S 50 BEST HOTELS 2025

Rosewood Hong Kong (No.1) has been named The World's Best Hotel 2025 The list celebrates hotels from 22 destinations across six…

4 months ago

Ascentage Pharma to Participate in Two Upcoming Investor Conferences in November 2025

October 29, 2025 20:00 ET  | Source: ASCENTAGE PHARMA GROUP INTERNATIONAL ROCKVILLE, Md. and SUZHOU, China, Oct. 29, 2025 (GLOBE…

4 months ago

Specialist Direct’s Mira Partners with dacadoo to Transform Recovery Management and Wellness Outcomes

Strategic integration of advanced health engagement technology to enhance recovery journeys and promote healthier lifestyles October 29, 2025 20:00 ET…

4 months ago

ibex Bohol Awarded First-Ever TESDA Enterprise-Based Education and Training Accreditation in Region

Milestone accreditation underscores ibex’s role as a leader in community-focused workforce training October 28, 2025 21:00 ET  | Source: Ibex…

4 months ago

The Capital Link Investigates: Opioid Story Retraction, Claims Unverified

New York, NY, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Opioid Story Retraction: Claims Unverified Rothstein’s inclination to favor a sensational…

4 months ago

Humanoid Global Welcomes Saman Farid to its Investment Advisory Board

– NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES – October 27, 2025 04:00 ET  |…

4 months ago

Health Canada Grants Authorization for LEQEMBI (lecanemab) for the Treatment of Early Alzheimers Disease

In Canada, lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment or…

4 months ago

Avacta presents first preclinical data from dual payload pre|CISION medicines at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets

First-in-class dual payload peptide drug conjugate delivers two complementary therapies from a single molecule with potential to overcome resistance and…

4 months ago